Fortifying food with folic acid to prevent neural tube defects: Are we now where we ought to be?

American Journal of Clinical Nutrition

Volumn 107, Issue 6, 2018, Pages 857-858

  Molloy, Anne M ^a   Mills, James L ^b  

^a TRINITY COLLEGE DUBLIN   (Ireland)

^b EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FOLIC ACID;

ANENCEPHALUS; CEREAL; DIET SUPPLEMENTATION; DIETARY SUPPLEMENT; EDITORIAL; ERYTHROCYTE; FORTIFIED FOOD; HEREDITY; HUMAN; NEURAL TUBE DEFECT; PRACTICE GUIDELINE; PREVENTIVE HEALTH SERVICE; PUBLIC HEALTH SERVICE; SPINAL DYSRAPHISM; UNITED STATES; FEMALE; STANDARDS;

FEMALE; FOLIC ACID; FOOD, FORTIFIED; HUMANS; NEURAL TUBE DEFECTS; UNITED STATES; UNITED STATES PUBLIC HEALTH SERVICE;

EID: 85048652670     PISSN: 00029165     EISSN: 19383207     Source Type: Journal    
DOI: 10.1093/ajcn/nqy110     Document Type: Editorial

References (10)

1. Zaganjor I, Sekkarie A, Tsang BL, Williams J, Razzaghi H, Mulinare J, Sniezek JE, Cannon MJ, Rosenthal J. Describing the prevalence of neural tube defects worldwide: a systematic literature review. PloS One 2016;11(4):e0151586.
2. Pfeiffer CM, Sternberg MR, Fazili Z, Lacher DA, Zhang M, Johnson CL, Hamner HC, Bailey RL, Rader JI, Yamini S. Folate status and concentrations of serum folate forms in the US population: National Health and Nutrition Examination Survey 2011-2. Br J Nutr 2015; 113:1965-77.
3. Crider KS, Qi YP, Devine O, Tinker SC, Berry RJ.Modeling the impact of folic acid fortification and supplementation on red blood cell folate concentrations and predicted neural tube defect risk in theUnited States: have we reached optimal prevention? Am J Clin Nutr 2018; 107:1027-34.
4. Crider KS, Devine O, Hao L, Dowling NF, Li S, Molloy AM, Li Z, Zhu J, Berry RJ. Population red blood cell folate concentrations for prevention of neural tube defects: Bayesian model. BMJ (Clin Res Ed) 2014;349:g4554.
5. Daly LE, Kirke PN, Molloy A, Weir DG, Scott JM. Folate levels and neural tube defects: implications for prevention. JAMA 1995;274:1698-702.
6. Bibbins-Domingo K, Grossman DC, Curry SJ, Davidson KW, Epling JW Jr., Garcia FA, KemperAR, Krist AH, KurthAE, Landefeld CS et al. Folic acid supplementation for the prevention of neural tube defects: US Preventive Services Task Force Recommendation Statement. JAMA 2017;317:183-9.
7. WHO. WHO Guideline: optimal serum and red blood cell folate concentrations in women of reproductive age for prevention of neural tube defects. Geneva (Switzerland): WHO; 2015.
8. Molloy AM, Pangilinan F, Brody LC. Genetic risk factors for folateresponsive neural tube defects. Ann Rev Nutr 2017;37:269-91.
9. Mosley BS, Cleves MA, Siega-Riz AM, Shaw GM, Canfield MA, Waller DK, Werler MM, Hobbs CA. Neural tube defects and maternal folate intake among pregnancies conceived after folic acid fortification in the United States. Am J Epidemiol 2009;169:9-17.
10. Ahrens K, Yazdy MM, Mitchell AA, Werler MM. Folic acid intake and spina bifida in the era of dietary folic acid fortification. Epidemiology 2011;22:731-7.